Effect of environment on growth: Auxological and hormonal parameters in African and Italian children

Growth Hormone and IGF Research

Volumn 19, Issue 3, 2009, Pages 238-241

  Boschetti, Mara ^a   Larizza, Daniela ^b   Calcaterra, Valeria ^b   Arvigo, Marica ^a   Fazzuoli, Laura ^a   Battista, Eliana Di ^a   Ferone, Diego ^a   Minuto, Francesco M ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

Height secular trend; IGF I; IGF II; Nutrition

Indexed keywords

SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

AFRICA; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CHILD; CHILD GROWTH; CHILD NUTRITION; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FEMALE; HUMAN; INFANT; ITALY; MALE; NORMAL HUMAN; POVERTY; PRIORITY JOURNAL;

AFRICA; BODY CONSTITUTION; BODY HEIGHT; BODY MASS INDEX; CHILD; CHILD, PRESCHOOL; ENVIRONMENT; FEMALE; HUMANS; INFANT; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; ITALY; MALE; NUTRITIONAL STATUS; RADIOIMMUNOASSAY; SUPEROXIDE DISMUTASE;

EID: 67349274121     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2008.10.005     Document Type: Article

References (19)

1. Steckel R. Stature and the standard of living. J. Econ. Lit. 33 (1995) 1903-1940
2. A. Fornasin, L. Quaranta, La statura degli italiani nati dal 1854 al 1890. Prime ipotesi per la costruzione di una nuova serie storica, downloaded from the website of the University of Udine, 2006, .
3. Tanner J.M. The secular trend towards earlier physical maturation. T Soc. Geneesk 44 (1966) 524-538
4. Zapf J., and Froesch E.R. Insulin-like growth factors/somatomedins: structure, secretion, biological actions and physiological role. Horm. Res. 24 (1986) 121-130
5. Froesch E.R., Hussain M.A., Schmid C., and Zapf J. Insulin-like growth factor I: physiology, metabolic effects and clinical uses. Diabetes Metab. Rev. 12 (1996) 195-215
6. Daughaday W.H., Mariz I.K., and Blethen S.L. Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites: a comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol-extracted serum. J. Clin. Endocrinol. Metab. 51 (1980) 781-788
7. Tanner J.M., and Whitehouse R.H. Clinical longitudinal standards for hight, weight, height velocity, weight velocity and stages of puberty. Arch. Dis. Child 51 (1976) 170-179
8. Unden A.L., Elofsson S., Knox S., Lewitt M.S., and Brismar K. IGF-I in a normal population: relation to psychosocial factors. Clin. Endocrinol. (Oxf.) 57 (2002) 793-803
9. Isley W.L., Underwood L.E., and Clemmons D.R. Dietary components that regulate serum somatomedin-C concentrations in humans. J. Clin. Invest. 71 (1983) 175-182
10. Heald A.H., Sharma R., Anderson S.G., Vyas A., Siddals K., Patel J., Bhatnagar D., Prabharkaran D., Rudenski A., Hughes E., Durrington P., Gibson J.M., and Cruickshank J.K. Dietary intake and the insulin-like growth factor system: effects of migration in two related populations in India and Britain with markedly different dietary intake. Public Health Nutr. 8 (2005) 620-627
11. De Flora S., Quaglia A., Bennicelli C., and Vercelli M. The epidemiological revolution of the 20th century. FASEB J. 19 (2005) 892-897
12. Zapf J., Schoenle E., Widmer U., and Froesch E.R. Biological effects of the insulin-like growth factors in vitro: relevance of their action in vivo. Bull. Schweiz. Akad. Med. Wiss. 1982 (1982) 171-182
13. Merimee T.J., Zapf J., and Froesch E.R. Insulin-like growth factors in the fed and fasted states. J. Clin. Endocr. Metab. 55 (1982) 99-102
14. Zapf J., Schoenle E., Widmer U., and Froesch E.R. Biological effects of the insulin-like growth factors in vitro: relevance to their actions in vivo. Bull. Schweiz. Akad. Med. Wiss. (1982) 171-182
15. Jones J., and Clemmons D.R. Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev. 16 (1995) 3-34
16. Steele-Perkins G., Turner J., Edman J.C., Hari J., Pierce S.B., Stover C., Rutter W.J., and Roth R.A. Expression and characterization of a functional human insulin-like growth factor I receptor. J. Biol. Chem. 263 (1988) 11486-11492
17. Smith W.J., Underwood L.E., Keyes L., and Clemmons D.R. Use of insulin like Growth factor I (IGF-I) and IGF-binding protein measurement to monitor feeding of premature infants. J. Clin. Endocrinol. Metab. 82 (1997) 3982-3988
18. Juul A., Dalgaard P., Blum W.F., Bang P., Hall K., Michaelsen K.F., Muller J., and Skakkebaek N.E. Serum levels of insulin-like growth factor (IGF)-binding protein- 3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation. J. Clin. Endocrinol. Metab. 80 (1995) 2534-2542
19. Yakar S., Setser J., Zhao H., Stannard B., Haluzik M., Glatt V., Bouxsein M.L., Kopchick J.J., and LeRoith D. Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1-deficient mice. J. Clin. Invest. 113 (2004) 96-105